Ryuta Tagawa

Real-World Incidence of Febrile Neutropenia among Patients Treated with Single-Agent Amrubicin: Necessity of the Primary Prophylactic Administration of Granulocyte Colony-Stimulating Factor

K. Ashizawa, M. Shimada, M. Fukuda, 2021, Journal of clinical medicine.

Immunosuppressive tumor microenvironment in extraskeletal myxoid chondrosarcoma: A case of pleural metastases

M. Shimada, H. Mukae, Yosuke Dotsu, 2022, Thoracic cancer.

Hypertrophic osteoarthropathy associated with lung cancer: Possible links among hypoxia‐inducible factor‐1α, vascular endothelial growth factor, and hypervascularization

Shota Nakashima, H. Mukae, H. Soda, 2023, Thoracic cancer.

Three-Dimensional Sulfonated Graphene Oxide Proton Exchange Membranes for Fuel Cells

M. Fukuda, S. Hayami, M. A. Rahman, 2023, ACS Applied Nano Materials.

Enhanced mixed proton and electron conductor at room temperature from chemically modified single-wall carbon nanotubes

M. Fukuda, S. Hayami, Md. Saidul Islam, 2022, RSC advances.

Proportion of biopsy specimens containing a tumor when compared to all biopsy specimens by transbronchial biopsy

Y. Obase, M. Fukuda, H. Mukae, 2022, Lung cancer management.

Phase II study of IRInotecan treatment after COmbined chemo‐immunotherapy for extensive‐stage small cell lung cancer: Protocol of IRICO study

M. Shimada, H. Mukae, H. Soda, 2023, Thoracic cancer.